Atrial fibrillation trials recruiting in Maryland

All Atrial fibrillation trials nationally

Cities in Maryland

Recruiting trials in Maryland

• 320-detector Computed Tomography to Assess Myocardial Extracellular Volume Fraction in Patients With Atrial Fibrillation Before AF Ablation.
  NCT06308094 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years and older · Sex: All (male and female) · Maryland: Baltimore
• A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
  NCT06455098 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Maryland: Baltimore
• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
  NCT04045665 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore, Bethesda
• BoxX-NoAF Clinical Trial
  NCT06989775 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Mobile Health Technology-Enabled AFib Management
  NCT06500988 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
  NCT05724121 · Phase: Not specified · Ages: 18 Years to 110 Years · Sex: All (male and female) · Maryland: Bethesda
• Optimal Pacing Rate for Cardiac Resynchronization Therapy
  NCT06445439 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female) · Maryland: Baltimore, Clinton
• Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
  NCT04088071 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Lanham
• Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
  NCT06735534 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
  NCT07175428 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Ft. Washington
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
  NCT07626411 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Ft. Washington
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female) · Maryland: Baltimore, Lanham, Rockville, Salisbury
• The Fourth Left Atrial Appendage Occlusion Study
  NCT05963698 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
  NCT05836987 · Phase: Phase 3 · Ages: 22 Years to 85 Years · Sex: All (male and female) · Maryland: Baltimore